---
title: "Tolazoline - Persistent pulmonary hypertension of the newborn"
sidebar: mydoc_sidebar
permalink: db00797-mesh-d010547-1.html
toc: false 
---


Path ID: `DB00797_MESH_D010547_1`
{% include image.html url="images/db00797-mesh-d010547-1.png" file="db00797-mesh-d010547-1.png" alt="db00797-mesh-d010547-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D014043 | tolazoline | Drug |
| UniProt:P35367 | Histamine H1 receptor | Protein |
| UniProt:P25021 | Histamine H2 receptor | Protein |
| UniProt:P35348 | Alpha-1A adrenergic receptor | Protein |
| UniProt:P08913 | Alpha-2A adrenergic receptor | Protein |
| REACT:R-HSA-416476 | G alpha (q) signalling events | Pathway |
| REACT:R-HSA-416482 | G alpha (12/13) signalling events | Pathway |
| REACT:R-HSA-418594 | G alpha (i) signalling events | Pathway |
| REACT:R-HSA-418597 | G alpha (z) signalling events | Pathway |
| GO:0042310 | vasoconstriction | BiologicalProcess |
| GO:0042311 | vasodilation | BiologicalProcess |
| MESH:D010547 | Persistent pulmonary hypertension of the newborn | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Tolazoline | POSITIVELY REGULATES | Histamine H1 Receptor |
| Tolazoline | POSITIVELY REGULATES | Histamine H2 Receptor |
| Histamine H1 Receptor | POSITIVELY REGULATES | Vasodilation |
| Histamine H2 Receptor | POSITIVELY REGULATES | Vasodilation |
| Vasodilation | NEGATIVELY CORRELATED WITH | Persistent Pulmonary Hypertension Of The Newborn |
| Tolazoline | NEGATIVELY REGULATES | Alpha-1A Adrenergic Receptor |
| Tolazoline | NEGATIVELY REGULATES | Alpha-2A Adrenergic Receptor |
| Alpha-1A Adrenergic Receptor | PARTICIPATES IN | G Alpha (Q) Signalling Events |
| Alpha-1A Adrenergic Receptor | PARTICIPATES IN | G Alpha (12/13) Signalling Events |
| Alpha-2A Adrenergic Receptor | PARTICIPATES IN | G Alpha (I) Signalling Events |
| Alpha-2A Adrenergic Receptor | PARTICIPATES IN | G Alpha (Z) Signalling Events |
| G Alpha (Q) Signalling Events | POSITIVELY REGULATES | Vasoconstriction |
| G Alpha (12/13) Signalling Events | POSITIVELY REGULATES | Vasoconstriction |
| G Alpha (I) Signalling Events | POSITIVELY REGULATES | Vasoconstriction |
| G Alpha (Z) Signalling Events | POSITIVELY REGULATES | Vasoconstriction |
| Vasoconstriction | POSITIVELY CORRELATED WITH | Persistent Pulmonary Hypertension Of The Newborn |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00797#mechanism-of-action](https://go.drugbank.com/drugs/DB00797#mechanism-of-action)
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL770/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL770/)
  - [https://en.wikipedia.org/wiki/Persistent_fetal_circulation#Treatment](https://en.wikipedia.org/wiki/Persistent_fetal_circulation#Treatment)

Reference: 
  - [https://go.drugbank.com/drugs/DB00797#mechanism-of-action](https://go.drugbank.com/drugs/DB00797#mechanism-of-action)
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL770/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL770/)
  - [https://en.wikipedia.org/wiki/Persistent_fetal_circulation#Treatment](https://en.wikipedia.org/wiki/Persistent_fetal_circulation#Treatment)

Reference: 
  - [https://go.drugbank.com/drugs/DB00797#mechanism-of-action](https://go.drugbank.com/drugs/DB00797#mechanism-of-action)
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL770/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL770/)
  - [https://en.wikipedia.org/wiki/Persistent_fetal_circulation#Treatment](https://en.wikipedia.org/wiki/Persistent_fetal_circulation#Treatment)
